|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 206.90 PLN | -1.71% |
|
-5.00% | +34.42% |
| 07-15 | Bayer, RAGT Enter Licensing Deal to Launch Hybrid Wheat Seeds | MT |
| 07-14 | ORIC Pharmaceuticals Starts Phase 3 Trial of Rinzimetostat in Metastatic Prostate Cancer | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BAYER AG | Other Pharmaceuticals | -1.71% | -5.00% | - | - | - | 53.63B |
-
|
-
|
-
|
- Stock Market
- Stocks
- BAYN Stock
- BAY Stock
- Charts Bayer AG
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
